Simcha Therapeutics is based in New Haven, Connecticut. It has raised $65M in total funding.
Simcha Therapeutics funding overview
Simcha Therapeutics is based in New Haven, Connecticut. Simcha Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Simcha Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include SR One Capital Management, BVF Partners, Samsara BioCapital, Rock Springs Capital, ArrowMark Partners, Logos Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Simcha Therapeutics at a glance
Total raised
$65M
Latest round date
January 2022
Headquarters
New Haven, Connecticut
Notable investors
SR One Capital Management, BVF Partners, Samsara BioCapital, Rock Springs Capital, ArrowMark Partners, Logos Capital, Westlake Village BioPartners, Connecticut Innovations
Frequently asked about Simcha Therapeutics funding
How much has Simcha Therapeutics raised?
Simcha Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Simcha Therapeutics?
SR One Capital Management, BVF Partners, Samsara BioCapital, Rock Springs Capital, ArrowMark Partners, Logos Capital are named among the investors backing Simcha Therapeutics.
What was the latest Simcha Therapeutics funding round?
No round stage has been disclosed for Simcha Therapeutics.
Where is Simcha Therapeutics based?
Simcha Therapeutics is based in New Haven, Connecticut.
When did Simcha Therapeutics last raise?
The last disclosed Simcha Therapeutics round closed in January 2022.
Simcha Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New Haven below to benchmark round size and investor mix.
